Phaeosynt

Hanover, Germany

Phaeosynt is a biotechnology company that produces animal-free antibodies using microalgae and diatomaceous earth.

$1.8M raised

Feb 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Phaeosynt raised?

Phaeosynt has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in February 2025.

Who are Phaeosynt's investors?

Phaeosynt's investors include NBank, Susanna Zapreva, PSD Bank Braunschweig, FONDE Ventures.

Where is Phaeosynt headquartered?

Phaeosynt is headquartered in Hanover, Germany.

What does Phaeosynt do?

Phaeosynt is a biotechnology company that produces animal-free antibodies using microalgae and diatomaceous earth.

What stage is Phaeosynt at?

Phaeosynt is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 12, 2025.

MLA

"Phaeosynt — Funding & Investors." VCBacked, February 12, 2025, https://www.vcbacked.co/company/phaeosynt. Accessed July 2, 2026.

APA

VCBacked. (2025). Phaeosynt — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/phaeosynt

Wikipedia (cite web)

{{cite web |title=Phaeosynt — Funding & Investors |url=https://www.vcbacked.co/company/phaeosynt |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 12, 2025.